Genetics company Oxford Biomedica has announced "significant advances" in its attempt to develop a treatment for Parkinson's disease.
The company, based at Oxford Science Park, presented its latest results to the Forum for European Neurosciences 2000 at Brighton.
Its scientists have used a horse virus called equine infectious anaemia to transfer therapeutic genes to human brain cells. The new genes are designed to re-programme the brain and halt the degeneration associated with Parkinson's.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article